Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
RO7444973 for Solid Tumors
Recruiting1 awardPhase 1
New Haven, Connecticut
This trial is testing a new drug, RO7444973, for safety and effectiveness in people with unresectable and/or metastatic melanoma-associated antigen A4 (MAGE-A4)-positive, solid tumors who carry the HLA-A*02:01 allele.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.